Covid 4th wave: DCGI approves emergency use of Bharat Biotech's Covaxin for children aged 6-12 years

DCGI has approved the emergency use authorisation for Bharat Biotech's Covaxin for children aged 6-12 years.

Covid 4th wave: DCGI approves emergency use of Bharat Biotech's Covaxin for children aged 6-12 years
DCGI has approved the emergency use authorisation for Bharat Biotech's Covaxin for children aged 6-12 years.